Dr. Alan Smith is the Associate Director of Bioinformatics at Stemina Biomarker Discovery. His current research involves the development of computational procedures and experimental designs for identification of predictive metabolic signatures for applications in predictive toxicology and clinical diagnostics. Dr. Smith developed Stemina Biomarker Discovery’s non-targeted discovery metabolomics pipeline that incorporates a unique array of proprietary data processing algorithms.
Dr. Smith has utilized the metabolomics platform to create predictive metabolic models of developmental toxicity utilizing human pluripotent stem cells, cardiotoxicity in induced pluripotent stem cell derived cardiomyocytes, and identified biomarkers related to metabolic subtypes of autism spectrum disorder.
Dr. Smith completed his Bachelor’s and Master’s Degrees in Biology at Indiana University-Purdue University Fort Wayne and received his Ph.D. from the University of Wisconsin-Madison in Plant Breeding and Plant Genetics.